T cell responses specific for tumor-associated antigens (TAA) presented by MHC molecules on cancer cells play a central role in cancer immune surveillance, and can be increased by different immunotherapy strategies in attempts to cure cancer [3]. This evidence concerns the gene HLA-C and cancer.